The database will be available to researchers at 55 medical centers and universities supported by the Clinical and Translational Sciences Award from the National Institutes of Health.
The company will use GSG Mess-und Analysnegerate for marketing and distribution in Germany, Austria, and Switzerland.
Topin will create a marketing strategy around OnDose, prepare marketing materials, and conduct meetings to educate oncologists about the pharmacokinetic test.
QDx will develop, market, and process the QPredict Prostate Mitomic Test, which will be based on Mitomics' flagship mitochondrial DNA-based prostate cancer diagnostic.
The deal makes Bulldog the single source of Dualsystems' products in the US.
The agreement covers Conexio's SBT Resolver products, which are locus-specific PCR-based HLA sequencing-based typing reagents, and includes kits and analysis software.
According to Response Biomedical, the Canadian point-of-care market is expected to reach $66.2 million this year and to grow at 7 percent over the next few years.
Med BioGene's shareholders have approved the deal, which gives Precision rights to commercialize Med BioGene's gene expression-based test for early stage non-small-cell lung cancer.
Magellan anticipates marketing a family of Miacom sepsis tests in the US for research use only, while starting clinical trials in preparation of submission to the US Food and Drug Administration.
Under one deal, AstraNet will sell Norton's protein aggregation monitoring device in Europe, while under another, Advanced Scientific Technologies will sell PAM in the mid-Atlantic region.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.